-
Is It Possible To Opt-Out? Facial Recognition Technology Raises Questions About Data And Consent
As facial recognition technology continues to quickly crop up around the globe, many are calling for a halt to its applications. -
Skeptic Of World Being Round Dies In California Rocket Crash
A California man who said he wanted to fly to the edge of outer space to see if the world is round has died after his home-built rocket blasted off into the desert sky and plunged back to earth. -
Study Finds Century-old Combat Helmet Superior Shield Against Brain Trauma
Combat helmets have always been made to protect against blunt objects, not blast waves. Despite improvements in helmet design, battlefield brain injuries continue. -
Hunt For New Coronavirus Treatments Includes Gene-Silencing And Monoclonal Antibodies
The new coronavirus has spurred biotech labs in universities and companies to try to find new approaches to stopping the virus — from blocking its key enzymes to interfering with its genetics. -
Jeff Bezos Commits $10 Billion To Fight Climate Change
Bezos, the world’s richest man, said in an Instagram post Monday that he'll start giving grants this summer to scientists, activists and nonprofits. -
Mass. Senate Passes Mental Healthcare Overhaul
State Senator Julian Cyr was a major backer of the bill -
Rare Weedy Seadragons Hatch At California Aquarium
After years of trying, a Southern California aquarium has two very tiny — and very rare — bundles of joy.Two weedy seadragons recently hatched at Birch… -
Boston Researchers Tackle The Coronavirus Vaccine
Local experts are attempting to tackle the complex process of creating a vaccine for COVID-19, the disease caused by the novel coronavirus. -
After Iowa Debacle, Tech Experts Who Aid Progressives Call For A Strategic Shake-Up
The failure of this year's Iowa caucuses was years in the making, some technology specialists argue, in part because of the haphazard way political users buy software. -
Timetable For A Vaccine Against The New Coronavirus? Maybe This Fall
Recent advances in biotech make scientists optimistic that they might have a vaccine that has passed basic tests of human safety and efficacy ready to go to clinics as soon as this fall.
